1443 related articles for article (PubMed ID: 18950759)
1. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
Fertil Steril; 2009 Feb; 91(2):456-88. PubMed ID: 18950759
[TBL] [Abstract][Full Text] [Related]
2. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.
Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
J Clin Endocrinol Metab; 2006 Nov; 91(11):4237-45. PubMed ID: 16940456
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
[TBL] [Abstract][Full Text] [Related]
4. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
Ezeh U; Ezeh C; Pisarska MD; Azziz R
Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
[TBL] [Abstract][Full Text] [Related]
5. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome in adolescent girls.
Baldauff NH; Witchel SF
Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
[TBL] [Abstract][Full Text] [Related]
7. European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire.
Conway G; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Franks S; Gambineri A; Kelestimur F; Macut D; Micic D; Pasquali R; Pfeifer M; Pignatelli D; Pugeat M; Yildiz B;
Eur J Endocrinol; 2014 Oct; 171(4):489-98. PubMed ID: 25049203
[TBL] [Abstract][Full Text] [Related]
8. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
Azziz R
J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
10. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
[TBL] [Abstract][Full Text] [Related]
11. Polycystic Ovary Syndrome.
Azziz R
Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
[TBL] [Abstract][Full Text] [Related]
12. PCOS: a diagnostic challenge.
Azziz R
Reprod Biomed Online; 2004 Jun; 8(6):644-8. PubMed ID: 15169578
[TBL] [Abstract][Full Text] [Related]
13. Best methods for identification and treatment of PCOS.
Artini PG; Di Berardino OM; Simi G; Papini F; Ruggiero M; Monteleone P; Cela V
Minerva Ginecol; 2010 Feb; 62(1):33-48. PubMed ID: 20186113
[TBL] [Abstract][Full Text] [Related]
14. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.
Rosenfield RL
J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):412-9. PubMed ID: 25840648
[TBL] [Abstract][Full Text] [Related]
15. Secondary forms of polycystic ovary syndrome.
Kaltsas GA; Isidori AM; Besser GM; Grossman AB
Trends Endocrinol Metab; 2004 Jul; 15(5):204-10. PubMed ID: 15223049
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovarian syndrome.
Trikudanathan S
Med Clin North Am; 2015 Jan; 99(1):221-35. PubMed ID: 25456652
[TBL] [Abstract][Full Text] [Related]
17. [Body composition and polycystic ovary syndrome].
Zabuliene L; Tutkuviene J
Medicina (Kaunas); 2010; 46(2):142-57. PubMed ID: 20440089
[TBL] [Abstract][Full Text] [Related]
18. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.
Franks S
J Clin Endocrinol Metab; 2006 Mar; 91(3):786-9. PubMed ID: 16418209
[TBL] [Abstract][Full Text] [Related]
19. [Current diagnosis of polycystic ovary syndrome: expanding the phenotype but generating new questions].
Merino P; Schulin-Zeuthen C; Codner E
Rev Med Chil; 2009 Aug; 137(8):1071-80. PubMed ID: 19915773
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosing polycystic ovary syndrome in adolescent girls].
Drosdzol-Cop A; Sidło-Stawowy A; Sajdak D; Skrzypulec-Plinta V
Ginekol Pol; 2014 Feb; 85(2):145-8. PubMed ID: 24745161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
